The cerebral circulation is arguably the most important in the body because arrest of the circulation for 5 min can cause neuronal death. In order to optimise the delivery of oxygen and metabolic substrates to the brain, anaesthetists need a clear understanding of the anatomy of the cerebral circulation and CSF pathways, the physiology of the cerebral circulation and the effects of anaesthesia, intensive care and other therapeutic interventions on the cerebral circulation.
Anatomy

Arterial supply
The arterial supply of the brain arises from the internal carotid arteries (70%) and the vertebrobasilar system (30%). The internal carotid arteries give rise to the anterior and middle cerebral arteries on each side and the basilar artery divides into the two posterior cerebral arteries. The anterior communicating artery joins the two anterior cerebral arteries and a posterior communicating artery runs from the posterior cerebral artery to the internal carotid on each side. This anastomosis forms the Circle of Willis at the base of the brain (Fig.  1) . The anterior cerebral arteries supply most of the medial part of the cerebral hemispheres, the middle cerebral arteries supply most of the lateral sides of the hemispheres and the posterior cerebral artery supplies the occipital and inferior parts of the temporal lobes. There are extensive anastomoses between the individual vessels.
Venous drainage
The venous drainage is from the superficial cerebral veins to the dural sinuses which drain into the jugular bulbs. The pressure in the superficial cerebral veins is 2-4 mmHg higher than the intracranial pressure (ICP) to ensure venous outflow from the brain. Thus, ICP is the closest measurable pressure to cerebral venous pressure and the best estimate for cerebral perfusion pressure (CPP) is mean arterial pressure (MAP) minus ICP (CPP = MAP -ICP).
CSF pathways
The CSF pathways form a second circulation in the brain and are a major determinant of ICP. CSF is mainly produced by active secretion, involving Na + /K + -ATPase and carbonic anhydrase, from the choroid plexus in the lateral and third ventricles at a rate of about 0.4 ml.min -1 . From here, it circulates through the fourth ventricle and emerges through the foramina of Luschka and Magendie into the cerebellar cisterns. It passes over the surface of the cerebral hemispheres and is reabsorbed through the arachnoid villi into the When the compensatory mechanisms are exhausted, ICP will increase. This is because the skull is a closed box and an increase in the volume of one of its contents must be compensated by a decrease in the volume of another for ICP to remain constant.
Blood-brain barrier
The blood-brain barrier (BBB) prevents any free diffusion of blood-borne substances into the brain parenchymal space. It is due to the endothelial cells lining the vascular wall in the brain being tightly linked with junctional complexes that eliminate gaps between cells. Therefore, the endothelial cells of the brain play a critical role in performing essential biological functions including transport of micro-and macro-nutrients, receptor-mediated signalling, leukocyte trafficking and osmoregulation. A number of molecular proteins responsible for some of these unique properties have now been identified showing that the brain endothelium is a complex and dynamic biological system rather than an inert barrier. These include proteins involved in the formation and assembly of tight junctions, plasma membrane-embedded proteins responsible for transport of brain energy substrates and nutrients, the multidrug transporter protein, p-glycoprotein and other drug-rejecting proteins that protect the brain from foreign chemicals. The BBB acts as a semipermeable membrane and is effectively an osmometer. Therefore, hypotonic fluids, such as Hartmann's solution, will cause an increase in brain water.
Control of cerebral blood flow (CBF)
CBF is controlled by four main mechanisms: autoregulation, chemical, metabolic and neurogenic factors (Fig. 2) . The healthy new-born and very preterm respond to physiological stimuli in the same manner as the mature organism but, as in the adult, pathological states may impair these responses. The spinal cord also consists of neurones and it has been shown that spinal cord blood flow is controlled in a similar manner to CBF.
Autoregulation
Autoregulation keeps cerebral blood flow (CBF) constant between MAP values of 60-150 mmHg ( Fig. 2) , or CPP values of 50-140 mmHg, in normotensive patients and probably works through a combination of metabolic (most effective at low CPPs) and myogenic (effective at high CPPs) factors. There may also be some neurogenic control of autoregulation. Autoregulation is impaired by disease processes, such as head injury or cerebrovascular accidents, and by drugs that cause cerebral vasodilatation, such as volatile anaesthetic agents or glyceryl trinitrate. The limits of autoregulation are shifted to the right in chronic hypertension and are usually restored to normal when the hypertension is well controlled. Return to normal limits may not occur if there have been permanent structural changes in the vessels due to long-standing hypertension or in the elderly.
Chemical control
Chemical control includes the influence of changes in hydrogen ion concentrations in the brain due to metabolic activity and changes in arterial PCO 2 and PO 2 . Changes in PaCO 2 cause alterations in CBF with a linear response in the physiological range of 30% per kPa (Fig. 2 ). There is no further increase in CBF above 10.6 kPa due to maximal vasodilatation. There is little further reduction in CBF below 3.5 kPa and no further decrease below 2.6 kPa. There is a threshold response to changes in PaO 2 with no change in CBF until 7.5 kPa below which there is a dramatic increase in CBF. This is explained by the shape of the oxyhaemoglobin dissociation curve because CBF shows a linear response to changes in arterial oxygen content and a PaO 2 of 7.5 kPa corresponds to the beginning of the steep part of the curve. Breathing 100% oxygen causes a small (~10%) reduction in CBF.
The cerebral circulation 
Changes in cerebral metabolic rate
Changes in cerebral metabolic rate (CMR) will cause changes in CBF. However, under normal circumstances, local CBF may change but global flow remains constant. This is because, as one region of the brain becomes more active, another region usually becomes less active and there is diversion of blood flow from one region to another. However, any factor that causes a global increase in CMR will cause an increase in CBF. These factors include pyrexia, convulsions and the use of analeptic drugs. Factors such as hypothermia, coma and anaesthesia decrease CMR and CBF (Fig. 2) .
Neurogenic factors
According to traditional teaching, neurogenic factors have little influence on control of CBF. However, over recent years, it has become clear that they have a major effect. The cerebral blood vessels have a very rich innervation and the axons of these nerves contain a variety of neurotransmitters. It is difficult to explain their presence if they are not involved in cerebrovascular control. In addition, it has become clear that the metabolic theory of Roy and Sherrington (1890) does not completely explain the adjustment of CBF to metabolic needs. The increases in CBF may be out of proportion to metabolic demands, may occur without significant change in local metabolism and may be much faster than the accumulation of metabolic end-products. Therefore, it is likely that neurogenic stimuli act to produce rapid adjustment of CBF to metabolic demands and that metabolic and chemical factors are responsible for maintaining the changes.
Sympathetic fibres, which cause vasoconstriction, originate in the superior cervical ganglion and the stellate ganglion with norepinephrine, serotonin and neuropeptide Y as neurotransmitters. Parasympathetic fibres, which cause vasodilatation, originate from the sphenopalatine ganglion, the internal carotid mini-ganglion and the otic ganglion with acetyl choline, vasoactive intestinal polypeptide and nitric oxide as neurotransmitters. The trigemino-vascular fibres arise from the first division of the trigeminal ganglion and other sensory innervation arises from somato-sensory pathways relaying in the thalamus. The sensory innervation causes vasodilatation and the transmitters include substance P, calcitonin gene related peptide, cholecystokinin and neurokinin A. There are also opioid receptors on the cerebral vessels and activation of these receptors modulates the function of the other vasoregulatory mechanisms. It seems that the endogenous opioid system is a latent regulatory mechanism which only becomes important under conditions of stress.
Sympathetic nerves protect CBF and blood brain barrier function during hypertension and hypoxaemia and have trophic effects on cerebral vessels. The role of parasympathetic nerves is less well defined but they do contribute to cerebrovascular dilatation in several pathological conditions including ischaemia/reperfusion. Trigemino-vascular fibres appear to be involved in cerebrovascular dilatation during post-ischaemia reperfusion, post-seizure hyperaemia, cortical spreading depression and arterial hypotension. They may have a protective role against vasospasm in subarachnoid haemorrhage.
Blood rheology
Blood rheology has an effect on CBF and the optimum haematocrit to balance improvement in flow and oxygen carrying capacity is about 30%. Reduction of the haematocrit to 30% causes an increase in CBF velocity (CBFV) in the middle cerebral artery of about 20%. The change in CBFV is approximately 2% for each 1% decrease in haematocrit and arterial oxygen content. However, this increase in CBF does not improve oxygen transport or tissue oxygen delivery.
The cerebral circulation is particularly susceptible to vascular steal because of the major role that the large arteries play in the regulation of the vascular resistance in the brain. However, focal increases in blood flow in one region of the brain cause flow-mediated vasodilatation of large arteries upstream. This phenomenon is particularly well developed in the cerebral circulation.
Ischaemic thresholds
CBF is normally 50 ml 100 g -1 min -1 when the MAP is in the autoregulatory range but below an MAP of 60 mmHg, CBF passively follows MAP. At approximately 20 mmHg in normotensive individuals, the CBF is 20-25 ml 100 g -1 min -1 and there is a change in cerebral electrical activity. Electrical activity is lost when the MAP is approximately 15 mmHg with a CBF of about 15 ml 100 g -1 min -1 and ionic homeostasis is lost at about 10 mmHg when CBF is 10 ml 100 g -1 min -1 . The watershed zones at the periphery of the supply from the major vessels are particularly vulnerable to ischaemia, but collaterals do exist and animal studies show normalisation of flow 1 month after occlusion of the middle cerebral artery due to an increase in the luminal diameter of collaterals.
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Effects of anaesthesia and intensive care on the cerebral circulation
Anaesthetic agents
Anaesthetic agents may increase, decrease or have no effect on CBF. Agents that cause changes in CBF may do so by direct effects on the blood vessels, by changing cerebral metabolic rate or by causing respiratory depression and an increase in PaCO 2 . Changes in CBF cause corresponding changes in cerebral blood volume and an increase in ICP. Anaesthetics may increase ICP by other mechanisms, such as the muscle fasciculations caused by suxamethonium, or the involuntary movements associated with etomidate which act by increasing CVP. An increase in CVP will increase ICP by two mechanisms: (i) a reduction in cerebral venous drainage; and (ii) an increase in the pressure in the valveless epidural veins squeezing CSF from the vertebral canal into the cranium. Anaesthetic agents may also have an effect on the rate of production of CSF and their effects are summarised in Table 1 . Bolus doses of the potent short-acting opioids may cause an increase in ICP secondary to acute cardiovascular effects, but this does not occur with infusions. The effects of drugs on the cerebral circulation may be modified by co-administration with other agents or by cerebral pathology.
Anaesthetic and intensive care interventions
Anaesthetic and intensive care interventions may affect the cerebral circulation and increase ICP. Laryngoscopy, intubation and extubation cause a sudden increase in MAP that temporarily increases CBF until autoregulation takes effect. Hypoxia and hypercarbia both increase CBF (see above).
Interventions that increase intrathoracic pressure such as IPPV, PEEP, coughing and straining will increase ICP by increasing central venous pressure as described above. Posture may also increase ICP. The prone position will increase the central venous pressure. Neck rotation can kink the internal jugular veins and obstruct the cerebral venous drainage. The head-down position will also reduce cerebral venous drainage. Emergence from anaesthesia and sedation is associated with an increase in cerebral metabolic rate, CBF and ICP. Alterations in CPP can affect CBF, particularly if cerebral autoregulation is impaired.
Therapeutic considerations
Hyperventilation
Hyperventilation has long been used therapeutically to reduce ICP in patients with head injury and other intracranial pathologies, but a recent trial has confirmed that excessive reduction in PaCO 2 can be harmful. It is now generally accepted that, in head injured patients, hyperventilation should be limited to that required to produce a PaCO 2 of 3.5-4.0 kPa. Similar considerations apply to anaesthesia for operations on the cerebral vasculature because, in some patients undergoing surgical treatment of ruptured aneurysms, it is impossible to achieve normal cerebral oxygenation whilst the patient is hypocapnic.
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Manipulation of CPP
Manipulation of CPP is used in several clinical situations in an attempt to improve patient outcomes. It is now recommended that MAP is artificially raised for a short period after the restoration of spontaneous circulation following cardiac arrest and it is customary to maintain a CPP of at least 70 mmHg during the intensive care management of severe head injury. In the presence of normal autoregulation, an increase in CPP may cause cerebral vasoconstriction and a reduction in ICP that further increases cerebral perfusion pressure and reduces ICP. This has been termed the vasoconstriction cascade. Conversely, a reduction in CPP will cause cerebral vasodilatation which will further increase ICP and decrease CPP leading to further vasodilatation and a vicious cycle that has been termed the vasodilation cascade. If autoregulation is impaired, an increase in MAP will lead to an increase in CBF and ICP and possibly cause cerebral oedema.
Hypothermia
Hypothermia reduces cerebral electrical activity and depresses the metabolic processes required to maintain the integrity of the neurones. Animal work has shown that a reduction of body temperature by as little as 2 or 3°C has some cerebral protective effects. Consequently, mild hypothermia (34°C) is commonly used during clipping of cerebral aneurysms and there has been renewed interest in its use in the intensive care management of severe head injuries.
Cerebral vasospasm
Cerebral vasospasm is a frequent complication following aneurysmal subarachnoid haemorrhage thought to be caused by the breakdown products of blood in the subarachnoid space. It is most frequent 3-10 days after the haemorrhage and it is more severe with a larger blood load in the CSF.
Impaired endothelium-dependent relaxation, production of endothelium derived constricting factors, including endothelin, and impaired activity of potassium channels in the cerebral blood vessels may all contribute to the vasospasm. At present, the only effective treatment is to increase CBF by hypervolaemic haemodilution with or without induced hypertension. Hypertensive, hypervolaemic haemodilution has been termed 'Triple H' therapy and, before it is commenced, it is essential to exclude other causes of neurological deterioration such as intracranial haematoma, cerebral infarction or hydrocephalus by performing a CT scan. This treatment should be limited to hypervolaemic haemodilution in the presence of an unclipped aneurysm. If hypertension is used, it should initially be limited to a trial period of 6 h. If ineffective after 6 h, treatment should revert to hypervolaemic haemodilution alone because induction of hypertension may cause cardiac complications.
